Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 4/20 | 0.47 |
| ▸ | TOP1 | P11387 | 1/20 | 0.42 |
| ▸ | CYCS | P99999 | 3/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.41 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29558385 | 1.00 | TERT (0.47) | TERTTOP1CYCSABCG2ENPP2 | |
| Magnesium SCHEMBL29489413 | 0.98 | TERT (0.46) | TERTTOP1CYCSABCG2ENPP2 | |
| SCHEMBL29501686 | 0.98 | TERT (0.46) | TERTTOP1CYCSABCG2ENPP2 | |
| SCHEMBL30368182 | 0.98 | TERT (0.46) | TERTTOP1CYCSABCG2ENPP2 | |
| SCHEMBL15995094 | 0.98 | TERT (0.46) | TERTTOP1CYCSABCG2 | |
| SCHEMBL29812943 | 0.98 | TERT (0.46) | TERTTOP1CYCSABCG2ENPP2 | |
| Hydrochloric Acid SCHEMBL30558879 | 0.96 | TERT (0.45) | TERTTOP1CYCSABCG2 | |
| Hydrochloric Acid SCHEMBL4020921 | 0.96 | TERT (0.45) | TERTTOP1CYCSABCG2 | |
| Hydrochloric Acid SCHEMBL4020916 | 0.96 | TERT (0.45) | TERTTOP1CYCSABCG2ENPP2 | |
| SCHEMBL5013677 | 0.91 | TERT (0.41) | TERTTOP1CYCSABCG2ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 528 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260048152-A1 | GEMCITABINE INORGANIC-ORGANIC HYBRID NANOPARTICLES | KARLSRUHER INSTITUT FUER TECH KOERPERSCHAFT DES OEFFENTLICHEN RECHTS (DE) | 2026-02-19 | — | — | US | claimed |
| US-20230020025-A1 | DISPLAY ASSEMBLY FOR AN ELECTRONIC DEVICE THAT INCLUDES A BLUE LIGHT PROTECTIVE TRANSPARENCY | PPG INDUSTRIES OHIO, INC. (US) | 2023-01-19 | — | — | US | claimed |
| US-11491711-B2 | Method of making 3D printed objects using two distinct light sources | PHOTOCENTRIC LIMITED (GB) | 2022-11-08 | — | — | US | claimed |
| EP-4078253-A1 | DISPLAY ASSEMBLY FOR AN ELECTRONIC DEVICE THAT INCLUDES A BLUE LIGHT PROTECTIVE TRANSPARENCY | PPG Industries Ohio Inc. (US) | 2022-10-26 | — | — | EP | claimed |
| EP-3829565-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2021-06-09 | — | — | EP | claimed |
| US-20200282638-A1 | METHOD OF MAKING 3D PRINTED OBJECTS USING TWO DISTINCT LIGHT SOURCES | PHOTOCENTRIC LIMITED (GB) | 2020-09-10 | — | — | US | claimed |
| US-10610472-B2 | High energy visible light filter systems with yellowness index values | HIGH PERFORMANCE OPTICS, INC. (US) | 2020-04-07 | — | — | US | claimed |
| WO-2020025488-A1 | INORGANIC-ORGANIC HYBRID COMPOUNDS INCLUDING ORGANIC PLATINUM-CONTAINING ANIONS, FOR USE IN MEDICINE | Karlsruher Institut für Technologie (DE) | 2020-02-06 | — | — | WO | claimed |
| US-10420471-B2 | Method of deep tissue imaging using multi-photon excitation of a fluorophore | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2019-09-24 | — | — | US | claimed |
| US-20180064616-A1 | High Energy Visible Light Filter Systems with Yellowness Index Values | HIGH PERFORMANCE OPTICS, INC. (US) | 2018-03-08 | — | — | US | claimed |
| EP-2602654-A1 | Ophthalmic filter | Essilor International (Compagnie Générale D'Optique) (FR) | 2013-06-12 | — | — | EP | claimed |
| EP-2591396-A1 | HIGH ENERGY VISIBLE LIGHT FILTER SYSTEMS WITH YELLOWNESS INDEX VALUES | High Performance Optics, Inc. (US) | 2013-05-15 | — | — | EP | claimed |
| WO-2012006265-A1 | HIGH ENERGY VISIBLE LIGHT FILTER SYSTEMS WITH YELLOWNESS INDEX VALUES | HIGH PERFORMANCE OPTICS, INC. (US) | 2012-01-12 | — | — | WO | claimed |
| US-20110198538-A1 | INORGANIC-ORGANIC COMPOSITE LUMINOPHORE | Karlsruher Institut for Technologie (KIT) (DE) | 2011-08-18 | — | — | US | claimed |
| EP-2179006-A1 | INORGANIC-ORGANIC COMPOSITE FLUORESCENT SUBSTANCE | Karlsruher Institut für Technologie (DE) | 2010-04-28 | — | — | EP | claimed |
| WO-2009100800-A1 | INORGANIC-ORGANIC COMPOSITE FLUORESCENT SUBSTANCE | UNIVERSITÄT KARLSRUHE (TH) (DE) | 2009-08-20 | — | — | WO | claimed |
| EP-1301515-B1 | NON-GENOTOXIC METALLOPORPHYRINS AS SYNTHETIC CATALYTIC SCAVENGERS OF REACTIVE OXYGEN SPECIES | EUKARION INC (US) | 2005-01-19 | — | — | EP | claimed |
| US-6403788-B1 | METALLOENZYME MIMETICS USEFUL FOR TREATING, PREVENTING OR ARRESTING FREE RADICAL ASSOCIATED DISEASES OR CONDITIONS | EUKARION, INC. | 2002-06-11 | — | — | US | claimed |
| US-5103027-A | Catalyst selectivity | ARCO CHEMICAL TECHNOLOGY, L.P. (US) | 1992-04-07 | — | — | US | claimed |
| US-4746735-A | NITRATING AGENT, SOLVENT, SMALL AMOUNT OF SULFURIC ACID CATALYST | THE DOW CHEMICAL COMPANY (US) | 1988-05-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260048152-A1 | GEMCITABINE INORGANIC-ORGANIC HYBRID NANOPARTICLES | GOT1, RNMT, GNAO1 | TERT 589/4885TOP1 261/4885CYCS 3912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.